Search Results

Test Catalog

OXYCU - Overview: Oxycodone with Metabolite Confirmation, Random, Urine

Detection and quantification of oxycodone, oxymorphone, noroxycodone, and noroxymorphone in urine

LID - Overview: Lidocaine, Serum

Assessing optimal lidocaine dosing during the acute management of ventricular arrhythmias following myocardial infarction or during cardiac manipulation such as surgery Assessing potential lidocaine toxicity

ABYSR - Overview: Antibody Screen with Reflexed Antibody Identification, Blood

Detection of allo- or autoantibodies directed against red blood cell antigens in the settings of pretransfusion testing Evaluation of transfusion reactions Evaluation of hemolytic anemia

PA - Overview: Procainamide and N-Acetylprocainamide, Serum

Monitoring therapy with procainamide Assessing compliance Evaluating procainamide toxicity

AGDD - Overview: Alpha Globin Cluster Locus Deletion/Duplication, Varies

Diagnosis of alpha-thalassemia Carrier screening for individuals from high-risk populations for alpha-thalassemia This test is not useful for diagnosis or confirmation of beta-thalassemia or hemoglobinopathies.

CSMTU - Overview: Controlled Substance Monitoring Targeted Profile, 17 Drug Classes, Mass Spectrometry, Random, Urine

Detecting drug use involving stimulants, benzodiazepines, and opioids This test is not intended for use in employment-related testing.

HBCSN - Overview: Hepatitis B Virus Core Total Antibodies Screen, Serum

Diagnosis of recent or past hepatitis B Determination of occult hepatitis B in otherwise healthy hepatitis B virus carriers with negative test results for hepatitis B surface (HBs) antigen, anti-HBs, anti-hepatitis B core IgM, hepatitis...

HBCPR - Overview: Hepatitis B Virus Core Total Antibodies Prenatal, Serum

Diagnosis of recent or past hepatitis B in pregnant individuals Determination of occult hepatitis B in otherwise healthy hepatitis B virus carriers with negative test results for hepatitis B surface (HBs) antigen, anti-HBs, anti-hepatitis...

IFG23 - Overview: Intact Fibroblast Growth Factor 23, Serum

Diagnosing and monitoring tumor induced osteomalacia Diagnosing X-linked hypophosphatemia or autosomal dominant hypophosphatemic rickets Diagnosing familial tumoral calcinosis with hyperphosphatemia

AMA - Overview: Mitochondrial Antibodies (M2), Serum

Establishing the diagnosis of primary biliary cholangitis This test is not useful for indicating the stage or prognosis of the disease or for monitoring the course of the disease.

BRCAT - Overview: BRCA1/2 Mutation Analysis, Next-Generation Sequencing, Tumor

Identifying specific mutations within the BRCA1 and BRCA2 genes known to be associated with response to PARP inhibitors and sensitivity to platinum-based therapy This test is not intended for the evaluation of patients suspected of having...

PBC2 - Overview: SP100 and GP210 Antibodies, IgG, Serum

Evaluating the risk of primary biliary cholangitis in anti-mitochondrial antibody (AMA)-negative patients by identification of Sp100 and gp210 antibodies Estimating risk in AMA-positive patients with incomplete feature of disease

SPAGR - Overview: Special Red Cell Antigen Typing, Whole Blood

Additional proof of alloantibody specificity Determining possible antibody specificities in complex cases This test is not useful for the purpose of establishing paternity

T3FR - Overview: T3 (Triiodothyronine), Free, Serum

A second- or third-level test of thyroid function Confirmation of hyperthyroidism, supplementing the T4 (tetraiodothyronine), sensitive thyrotropin, and total T3 assays Evaluating clinically euthyroid patients who have an altered...

ROGM - Overview: Measles (Rubeola) Virus Antibody, IgM and IgG, Serum

Diagnosing measles virus infection Determination of immune status of individuals to the measles virus using IgG antibody testing Documentation of previous infection with measles virus in an individual without a previous record of...

LMALP - Overview: Malaria PCR with Parasitemia Reflex, Varies

Detection of Plasmodium DNA and identification of the infecting species, with reflex percent parasitemia calculated using thin blood films for positive cases An adjunct to conventional microscopy of Giemsa-stained films Detection and...

TBIDS - Overview: Culture Referred for Identification, Mycobacterium and Nocardia with Antimicrobial Susceptibility Testing, Varies

Rapid identification to the species level and susceptibility testing for Mycobacterium species, Nocardia species, and other aerobic actinomycete genera and species from pure culture isolates

PSYQP - Overview: Psychotropic Pharmacogenomics Gene Panel, Varies

Individualizing selection and dosage of medications prescribed for treatment of depression and other psychiatric disorders based on genetic variation Identifying genetic variation in genes known to be associated with response and/or risk...

2C19R - Overview: Cytochrome P450 2C19 Genotype, Varies

Identifying patients who may be at risk for altered metabolism of drugs that are modified by cytochrome P450 2C19 Predicting anticoagulation response to clopidogrel

TRYPP - Overview: Tryptophan, Plasma

Investigating inadequate tryptophan intake and monitoring dietary treatment

ULFAT - Overview: Cryptococcus Antigen Titer, Lateral Flow Assay, Urine

Aiding in the diagnosis of infection with Cryptococcus neoformans or Cryptococcus gattii This test should not be used as a test of cure.

6MAMX - Overview: 6-Monoacetylmorphine, Chain of Custody, Random, Urine

Determination of heroin use Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen by demonstrating that, it is always...

GATOL - Overview: Galactitol, Quantitative, Urine

Monitoring effectiveness of treatment in patients with galactosemia Establishing a baseline level prior to initiating treatment for galactosemia

MMAP - Overview: Methylmalonic Acid, Quantitative, Plasma

Evaluating children with signs and symptoms of methylmalonic acidemia using plasma specimens Evaluating individuals with signs and symptoms associated with a variety of causes of vitamin B12 (cobalamin) deficiency

MMAU - Overview: Methylmalonic Acid, Quantitative, Urine

Evaluating children with signs and symptoms of methylmalonic acidemia using urine specimens Evaluating individuals with signs and symptoms associated with a variety of causes of vitamin B12 (cobalamin) deficiency

MMAS - Overview: Methylmalonic Acid, Quantitative, Serum

Evaluating children with signs and symptoms of methylmalonic acidemia using serum specimens Evaluating individuals with signs and symptoms associated with a variety of causes of vitamin B12 (cobalamin) deficiency

ALCU - Overview: Aluminum/Creatinine Ratio, Urine

Measurement of aluminum concentration as a part of assessing for aluminum exposure

ABIDR - Overview: Antibody Identification, Blood and Serum

Assessing positive pretransfusion antibody screens, transfusion reactions, hemolytic disease of the newborn, and autoimmune hemolytic anemias This test is not useful for monitoring the efficacy of Rh-immune globulin administration. This...

ABTIR - Overview: Antibody Titer, Blood and Serum

Monitoring antibody levels during pregnancy to help assess the risk of hemolytic disease of the newborn This test is not useful for monitoring the efficacy of Rh-immune globulin administration.

GUSBW - Overview: Beta-Glucuronidase, Leukocytes

Supporting the biochemical diagnosis of mucopolysaccharidosis type VII (MPS VII, Sly syndrome) in whole blood This test is not useful for carrier detection.

CAURS - Overview: Candida auris Surveillance, Molecular Detection, PCR, Varies

Detecting Candida auris from surveillance swabs This test should not be used to determine cure or to monitor response to therapy.

MTBS - Overview: Microsporidia Stain, Varies

Diagnosis of extra-intestinal microsporidiosis involving the lung, skin, and other organs, particularly in immunocompromised hosts Diagnosis of ocular microsporidiosis

TB2LN - Overview: Susceptibility, Mycobacterium tuberculosis Complex, Second Line, Varies

Determination of Mycobacterium tuberculosis complex minimal inhibitory concentrations to second-line antimicrobial agents

G6PDZ - Overview: Glucose-6-Phosphate Dehydrogenase (G6PD) Full Gene Sequencing, Varies

Genetic test for individuals at high risk for glucose-6-phosphate dehydrogenase (G6PD) deficiency Aiding in the diagnosis of G6PD deficiency Determining G6PD deficiency status in individuals with inconclusive or unexpected phenotyping...

CHBVS - Overview: Chronic Hepatitis B Screen, Serum

Diagnosis and evaluation of patients at risk for or suspected of having chronic hepatitis B This test is not offered as a screening or confirmatory test for blood donor specimens. This test is not useful during the "window period" of...

CHSBP - Overview: Chronic Hepatitis B Monitoring Profile, Serum

Evaluating and monitoring individuals with known chronic hepatitis B Monitoring hepatitis B viral infectivity after resolution of acute hepatitis B

HCSRN - Overview: Hepatitis C Virus (HCV) Antibody Screen with Reflex to HCV RNA, PCR, Asymptomatic, Serum

Screening for hepatitis C virus (HCV) infection in primary care settings in high-risk persons with a current or previous history of illicit injection drug use or a history of receiving a blood transfusion prior to 1992 Screening for...

CSMHU - Overview: Controlled Substance Monitoring Hybrid Drug Profile, 20 Drug Classes, High-Resolution Mass Spectrometry and Immunoassay Screen, Random, Urine

Detecting drug use involving stimulants, barbiturate, benzodiazepines, cocaine, opioids, and tetrahydrocannabinol This test is not intended for use in employment-related testing.

CSMPU - Overview: Controlled Substance Monitoring Panel, Random, Urine

Detecting drug use involving stimulants, barbiturates, benzodiazepines, cocaine, opioids, and tetrahydrocannabinol This test is not intended for use in employment-related testing.

LEPDT - Overview: Leptospira, IgM, Serum

Aiding in the diagnosis of leptospirosis This test is not useful for establishing cure or response to therapy.

OPATU - Overview: Opiates Confirmation, Random, Urine

Detection and quantification of codeine, hydrocodone, oxycodone, morphine, hydromorphone, oxymorphone, noroxycodone, noroxymorphone, norhydrocodone, dihydrocodeine, and naloxone in urine

OXYSX - Overview: Oxycodone Screen, Chain of Custody, Random, Urine

Detection of oxycodone and oxymorphone in urine following chain-of-custody procedures This chain-of-custody test is intended to be used in a setting where the test results can be used definitively to make a diagnosis. Chain of custody is...

PCPMX - Overview: Phencyclidine (PCP) Confirmation, Chain of Custody, Meconium

Detection of in utero drug exposure up to 5 months before birth Chain of custody is required whenever the results of testing could be used in a court of law. Its purpose is to protect the rights of the individual contributing the specimen...

PIPU - Overview: Pipecolic Acid, Random, Urine

Differentiating between disorders of peroxisomal biogenesis (eg, Zellweger syndrome) and disorders with loss of a single peroxisomal function Detecting abnormal elevations of pipecolic acid in urine

Site Search

Register today for Classical Hematology 2023 - Insights

Taking place on October 3–4, 2023, in Rochester, Minnesota, the Classical Hematology 2023 conference focuses on addressing the evaluation of frequently encountered blood count abnormalities. The conference...

Visit Mayo Clinic Laboratories at Medlab Middle East 2023 - Insights

announce our participation in Medlab Middle East 2023, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 6–9, 2023....

Top 5 Mayo Clinic Laboratories advancements in 2024 - Insights

Five of the most significant advancements from Mayo Clinic Laboratories in 2024 to enhance diagnostics and patient care globally....

Visit Mayo Clinic Laboratories at Medlab Middle East 2024 - Insights

announce our participation in Medlab Middle East 2024, a medical conference and exhibition taking place in Dubai, United Arab Emirates, Feb. 5–8, 2024....

Managing Compliance in Preparation for 2025 Updates - Insights

With updates expected to federal compliance guidance for laboratories in 2025, now is a great time to revisit existing guidelines and plans....